Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 05, 2012 12:00 ET | Source: DUSA Pharmaceuticals, Inc.

Caraco Pharmaceutical Laboratories and DUSA Pharmaceuticals Announce Early Termination of the Hart-Scott-Rodino Waiting Period Relating to Tender Offer

DETROIT and WILMINGTON, Mass., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Caraco Pharmaceutical Laboratories, Ltd. ("CPL"), a wholly owned subsidiary of Sun Pharmaceutical Industries Limited ("Sun Pharma"), and...
November 08, 2012 06:36 ET | Source: DUSA Pharmaceuticals, Inc.

Sun Pharma to Acquire DUSA Pharmaceuticals, Inc.

WILMINGTON, Mass. and MUMBAI, India, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Sun Pharmaceutical Industries Limited ((Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715)) (together with its...
November 05, 2012 06:30 ET | Source: DUSA Pharmaceuticals, Inc.

DUSA Pharmaceuticals, Inc.(R) to Host Third Quarter 2012 Corporate Highlights and Financial Results Webcast and Conference Call

WILMINGTON, Mass., Nov. 5, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc. (Nasdaq:DUSA), announces that its third quarter 2012 corporate highlights and financial results press release will be...
September 13, 2012 06:30 ET | Source: DUSA Pharmaceuticals, Inc.

DUSA Pharmaceuticals Demonstrates Positive Results in Phase 2 Actinic Keratoses Extremities Study

Levulan® PDT Using Occlusion Results in an 89% AK Lesion Clearance Rate WILMINGTON, Mass., Sept. 13, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology...
September 04, 2012 08:00 ET | Source: DUSA Pharmaceuticals, Inc.

DUSA Pharmaceuticals to Present at the Rodman & Renshaw 14th Annual Healthcare Conference

WILMINGTON, Mass., Sept. 4, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT),...
August 02, 2012 06:30 ET | Source: DUSA Pharmaceuticals, Inc.

DUSA Pharmaceuticals Reports Second Quarter 2012 Corporate Highlights and Financial Results

Quarterly Domestic Kerastick® Revenues Up 22% Year-Over-Year; Quarterly Product Gross Margins Up 21% Year-Over-Year Conference call and audio webcast will be held today, August 2nd, at...
July 26, 2012 06:30 ET | Source: DUSA Pharmaceuticals, Inc.

DUSA Pharmaceuticals, Inc.(R) to Host Second Quarter 2012 Corporate Highlights and Financial Results Webcast and Conference Call

WILMINGTON, Mass., July 26, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc. (Nasdaq:DUSA) announces that its second quarter 2012 corporate highlights and financial results press release will be...
June 15, 2012 08:30 ET | Source: DUSA Pharmaceuticals, Inc.

DUSA Pharmaceuticals to Present at the Inaugural Marcum MicroCap Conference on June 20th in New York City

NEW YORK, June 15, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a specialty pharmaceutical company focused primarily on the development and marketing of its Levulan®...
June 07, 2012 06:30 ET | Source: DUSA Pharmaceuticals, Inc.

DUSA Pharmaceuticals, Inc.(R) to Webcast Annual Meeting of Shareholders

WILMINGTON, Mass., June 7, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc. (Nasdaq:DUSA) announces that it will host a live audio webcast of its Annual Meeting of Shareholders at 11:00am EDT on...
May 31, 2012 08:30 ET | Source: DUSA Pharmaceuticals, Inc.

DUSA Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference

WILMINGTON, Mass., May 31, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT),...